Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...

Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,588 ...

Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a pharmaceutical company with a market capitalization of $72.6 million, has ...

The global surface plasmon resonance (SPR) system market is on a steady growth trajectory, with a projected valuation of USD ...

The National Retail Federation event in 2024 was all about artificial intelligence. The same can be said for NRF 2025. Click ...

India has established itself as a global leader in pharmaceutical production, with potential for further growth through ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Doximity, Inc.